U.S. Auto Stock News

Choice Hotels International recently promoted longtime technology leader Tony Pallas to Chief Technology Officer and, earlier this month, opened its 30th Everhome Suites extended stay hotel in Georgetown, Texas, marking continued brand expansion since Everhome’s 2022 debut. These moves highlight how Choice Hotels is pairing rapid growth in extended stay with a sharper push into AI-enabled property and revenue management to support owners and guests. We’ll now explore how Everhome Suites’...

Earlier this month, Micron Technology appointed AI and cloud infrastructure veteran Dr. Alexis Black Björlin to its board and showcased an expanded portfolio of AI-optimized memory and storage at COMPUTEX 2026, spanning high-bandwidth memory, advanced DRAM, and next‑generation SSDs for data centers and edge devices. This combination of board-level expertise and a tiered AI memory stack reinforces Micron’s ambition to sit at the center of AI infrastructure, from hyperscale data centers to...

Mixed Q1 earnings keep focus on Tennant stock Tennant (TNC) has drawn fresh attention after Q1 results showed revenue up 2.7% year on year and earnings and EBITDA ahead of analyst expectations, but with the weakest full year guidance among water infrastructure peers. See our latest analysis for Tennant. At a share price of US$86.88, Tennant has seen momentum build, with a 30 day share price return of 7.63% and a 90 day share price return of 35.35%, contributing to an 18.25% one year total...

Earlier in June 2026, AMD outlined plans to invest up to £2 billion in the UK over five years, deepen AI collaborations with partners such as Oriole Networks and Dell, and power new national AI supercomputers at the University of Cambridge using its Instinct GPUs and EPYC processors. By tying its hardware, photonic networking experiments and research investments directly into the UK’s AI infrastructure and scientific programs, AMD is embedding its data center technology at the heart of...

Madrigal Pharmaceuticals recently presented at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami and is preparing to showcase multiple clinical and real‑world data abstracts on its MASH therapy Rezdiffra at the EASL Congress 2026. The mix of supportive and cautious analyst commentary around Rezdiffra’s commercial trajectory, combined with upcoming data disclosures, is sharpening focus on how durable physician demand and competitive pressures might shape Madrigal’s...

Celsius Holdings recently saw renewed attention after Bernstein initiated coverage with an Outperform rating and highlighted its evolution into a multi-brand energy beverage platform through the Alani Nu and Rockstar Energy acquisitions, alongside strong post-deal revenue growth and ongoing integration challenges. At the same time, regulatory scrutiny over alleged youth-focused marketing practices and an investor investigation have added a layer of legal and reputational risk that now sits...

In recent months, Procter & Gamble has coupled an AI-driven push to boost volumes and structural productivity with a sweeping leadership reshuffle across grooming, baby and feminine care, sustainability, and regional businesses. This combination of digital transformation, job cuts, and high-profile executive transitions is reshaping how the consumer giant balances efficiency, innovation, and long-term brand stewardship. Now we’ll examine how P&G’s AI-enabled productivity drive and...

Recent performance snapshot Huntsman (HUN) has attracted fresh attention after a period of strong share price moves, with the stock up 4.4% on the day, about 11% over the past week, and roughly 15% over the past month. Those gains come against a mixed fundamental picture, with revenue of US$5,693 million alongside a reported net loss of US$323 million, and a market value of about US$2.8b that reflects investor expectations for its specialty chemicals portfolio. See our latest analysis for...

Mineralys Therapeutics recently completed a US$150.0 million follow-on equity offering and entered a senior secured term loan facility of up to US$500.0 million, while presenting new lorundrostat biomarker data at major medical and investor conferences in June 2026. The proteomic findings that lorundrostat reduced biomarkers linked to heart failure risk may broaden its potential clinical relevance beyond blood pressure control. We’ll now explore how these new heart failure biomarker data for...

Graham Corporation recently reported fourth-quarter fiscal 2026 results, with sales rising to US$67.08 million but net income easing to US$1.97 million, and issued fiscal 2027 net sales guidance of US$285 million to US$295 million. Despite only a modest full-year net income increase to US$12.50 million, the company’s willingness to provide 2027 guidance gives investors clearer visibility into its near-term revenue expectations. We’ll now examine how Graham’s new 2027 sales guidance range...

Arch Capital Group (ACGL) has reshaped its leadership and balance sheet in quick succession, expanding President Maamoun Rajeh’s remit and issuing long dated fixed rate notes that could influence how investors think about the stock. See our latest analysis for Arch Capital Group. The leadership changes and long dated debt issuance come after a mixed recent run for the stock, with a 1 year total shareholder return of 0.57% sitting against a 5 year total shareholder return of 154.34%. If you...

Viper Energy recently reported past-year revenue growth of very large, beating EBITDA and EPS estimates and lifting its full-year oil production guidance on the back of stronger activity from its operating partner Diamondback Energy. The results have sparked a valuation debate, with some analyses flagging potential overvaluation while others highlight discounted cash flow models that suggest meaningful upside based on its royalty-focused Permian footprint and capital-light model. Now we'll...

In recent days, Chinese regulators reprimanded JD.com and other major e-commerce platforms for misleading advertising and irregular discounting during past 618 shopping festivals, ordering them to rectify practices that distorted pricing and obscured actual subsidies. This intervention not only tightens oversight of JD.com's high-profile promotions, but also raises fresh questions about how the company balances discount-driven growth with compliance and merchant profitability. We’ll now...

With the Federal Reserve widely expected to keep interest rates steady in June and July, markets are getting a rare dose of predictability. That kind of policy pause can give investors more room to focus on company fundamentals rather than guessing the next rate move. This article looks at three large North American technology related stocks exposed to this news, all screened for solid performance and financial health metrics. You will see how a stable rate outlook may shape the opportunity...

What Lumen’s latest earnings miss means for stockholders Lumen Technologies (LUMN) is back in focus after quarterly results showed revenue declining 2.7% year on year and missing analyst expectations by 16.3%. This has prompted a negative share price reaction and fresh questions around execution. Management has reiterated confidence in the current plan. However, the combination of weaker earnings, sector wide legacy pressures, and tougher competition is now central to how investors assess the...

LandBridge recently raised its full-year 2026 adjusted EBITDA guidance to US$210 million–US$230 million, citing a more favorable macro environment and stronger-than-expected fee-based activity across its Delaware Basin surface acreage portfolio. This upgraded outlook highlights how LandBridge’s asset-light, high-margin model can benefit from increased utilization of its land for energy and infrastructure projects without taking direct drilling or commodity price risk. We’ll now examine how...

Stock performance snapshot and context Marriott Vacations Worldwide (VAC) has drawn investor attention after a strong run in the stock, with gains over the past month and past 3 months prompting closer inspection of the company’s fundamentals and recent performance trends. See our latest analysis for Marriott Vacations Worldwide. That recent surge sits on top of a much longer rebuild in sentiment, with a 58.67% year to date share price return contrasting with a 45.12% total shareholder return...

AbCellera Biologics (ABCL) has drawn investor attention after appointing Victor Sandor, M.D.C.M, as an independent director. He brings drug development and regulatory approval experience from roles at Array BioPharma, Incyte, Biogen and AstraZeneca. See our latest analysis for AbCellera Biologics. The appointment of Victor Sandor comes as AbCellera’s share price has climbed 47.61% over the past 90 days and 52.77% year to date. The 1-year total shareholder return of 65.82% contrasts with a...

In recent months, Take-Two Interactive Software insiders, including Executive Chairman & CEO Strauss Zelnick, have sold large blocks of shares, while analysts and investors have focused on the company’s upcoming Grand Theft Auto VI release and its recent earnings beat. At the same time, investors are increasingly interested in Take-Two’s shift toward a platform-style model built around recurring spending, subscriptions, and persistent game worlds rather than one-off title launches. We’ll now...

Why AZZ stock is drawing attention now AZZ (AZZ) is back on investors’ radar after recent trading saw the stock move while key return figures stand out, putting its metal coatings and coil coating business in sharper focus. See our latest analysis for AZZ. Recent trading has been strong, with the latest share price at $150.89, a 90 day share price return of 21.9% and a 1 year total shareholder return of 68.75%, pointing to building momentum on both shorter and longer horizons. If AZZ’s run...

In early June 2026, GameStop reported first-quarter sales of US$835.3 million and net income of US$389.6 million, while unveiling a new US$2.00 billion share repurchase program running through 2029. At the same time, CEO Ryan Cohen launched a hostile takeover bid for eBay, signaling an effort to recast GameStop as a broader e-commerce and collectibles platform rather than a traditional bricks-and-mortar gaming retailer. We’ll now examine how GameStop’s aggressive US$2.00 billion buyback plan...

Bread Financial Holdings recently presented at the Morgan Stanley US Financials Conference in New York, where Executive VP & CFO Perry S. Beberman highlighted the company’s improving credit trends, including lower net principal losses and easing delinquencies. Analysts are increasingly focusing on how these better credit metrics, together with a run of positive earnings surprises and capital return activity, may be reshaping assessments of Bread Financial’s earnings power and risk...

Earlier in June 2026, Travere Therapeutics reported long-term Phase 3 DUPLEX open-label extension data showing durable proteinuria reductions and up to five years of tolerability for FILSPARI in focal segmental glomerulosclerosis, alongside its first non-GAAP profitable quarter driven by the drug’s commercial performance. This combination of sustained clinical benefit in a rare kidney disease and an early move into profitability highlights how central FILSPARI has become to Travere’s...

The sudden progress toward a US Iran peace deal and the potential reopening of the Strait of Hormuz has pulled oil prices lower and shifted attention to companies that are sensitive to fuel costs and global stability. For investors, this is a moment to reassess which stocks might benefit if cheaper energy and reduced geopolitical risk persist, and which could lose some pricing power. This article highlights 3 stocks from a Global Airlines and Travel screener that appear positively exposed to...